Molecular Modeling in Drug Design
Molecular recognition plays a central role in biological systems and is the basis of the specificity seen in antigen-antibody, substrate-enzyme, hormone-receptor, and drug-receptor interactions. The importance of this problem had been recognized by scientists like Pasteur and Ehrlich at the end of the nineteenth century. Structure-activity relations in which one probes the basis of recognition by chemically modifying one of the partners form a significant segment of medicinal chemistry. Attempts to correlate activity with physical properties such as solubility, refractive index, etc., are a reasonable approach to definining the characteristic properties associated with activity in a given biological assay (Hansch 1966). In most systems, these correlations reflect the effective concentration of the drug in the critical biophase rather than the critical features necessary for bimolecular recognition. We would like to concentrate on what can be deduced regarding bimolecular recognition from structure-activity data.
KeywordsDrug Design Orientation Space Pharmacophore Hypothesis Pharmacophoric Group Gamma Butyrolactone
Unable to display preview. Download preview PDF.
- Crippen GM (1981) Distance geometry and conformational calculations. In: Bawden D (ed) Chemometrics research studies series, vol 1. Wiley, ChichesterGoogle Scholar
- Fries DS, Portoghese PS (1976) Stereochemical studies on medicinal compounds. 20. Absolute configuration and analgetic potency of alpha-promedol enantiomers. The role of the C-4 chiral center in conferring stereoselectivity in axial- and equitorial-phenyl prodine congeners. J Med Chem 19: 1155–1158PubMedCrossRefGoogle Scholar
- Levine J A, Ferrendelli JA, Covey DF (1985) Convulsant and anti-eonvulsant gammabutyrol-actones bind to the picrotoxinin/t-butylbicyclophosphorothionate ( TBPS) receptor. Biochem Pharmacol 34: 4187–4190Google Scholar
- Marshall GR, Barry CD, Bosshard HE, Dammkoehler RA, Dunn DA (1979) The conformational parameter in drug design: the active analog approach. In: Olsen EC, Christoffersen RE (eds) Computer-assisted drug design. ACS symposium series 112. American Chemical Society, Washington, DC, pp 205–226CrossRefGoogle Scholar
- Mathews DA, Bolin JT, Burridge JM, Filman DJ, Volz KW, Kaufman BT, Beddell CR, Champness JN, Stammers DK, Kraut J (1985) Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J Biol Chem 260: 381–391Google Scholar
- Mayer D, Motoc I, Marshall GR (1986) Determination of an active site model of angiotensin converting enzyme. J Med Chem (in press)Google Scholar
- Motoc I, Dammkoehler RA, Marshall GR (1985) Three-dimensional structure-activity relationships and biological receptor mapping. In: Trinajstic N (ed) Application of mathematical concepts to chemistry. Ellis Horwood, Chichester (in press)Google Scholar
- Russell B (1945) A history of western philosophy. Simon and Schuster, New York, p 472Google Scholar